FABIANI, IACOPO
 Distribuzione geografica
Continente #
EU - Europa 410
AS - Asia 172
NA - Nord America 146
AF - Africa 3
OC - Oceania 3
SA - Sud America 1
Totale 735
Nazione #
IT - Italia 215
US - Stati Uniti d'America 139
SG - Singapore 114
RU - Federazione Russa 51
CN - Cina 36
IE - Irlanda 34
FI - Finlandia 33
DE - Germania 20
GB - Regno Unito 17
NL - Olanda 15
PK - Pakistan 8
BD - Bangladesh 7
BE - Belgio 7
CA - Canada 6
FR - Francia 4
LT - Lituania 4
AU - Australia 3
IN - India 3
MG - Madagascar 3
RO - Romania 3
AT - Austria 2
HU - Ungheria 2
PL - Polonia 2
BR - Brasile 1
ID - Indonesia 1
JP - Giappone 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
MX - Messico 1
SE - Svezia 1
Totale 735
Città #
Singapore 97
Dublin 34
Boardman 28
Helsinki 17
Florence 14
Lappeenranta 13
Munich 13
Santa Clara 13
Rome 12
Milan 11
Naples 11
Pisa 11
Assago 10
Genoa 8
Brussels 7
Lucca 7
Washington 7
Beijing 6
London 6
Palermo 6
Santa Croce sull'Arno 6
Cascina 5
Livorno 5
Seattle 5
Ashburn 4
Faisalabad 4
Toronto 4
Viareggio 4
Bucharest 3
Lahore 3
Los Angeles 3
Melbourne 3
Mumbai 3
Reggio Emilia 3
Verona 3
Aversa 2
Bari 2
Buti 2
Casalecchio di Reno 2
Catania 2
Cornaredo 2
Cosenza 2
Debrecen 2
Dongguan 2
Espoo 2
Gozzano 2
Kilburn 2
Nuremberg 2
Padova 2
Perugia 2
Reading 2
Salemi 2
Salerno 2
Shanghai 2
Shenzhen 2
Turin 2
Warsaw 2
Zhengzhou 2
Albavilla 1
Amsterdam 1
Bergamo 1
Berlin 1
Casorate Sempione 1
Changsha 1
Clifton 1
Fayetteville 1
Frankfurt am Main 1
Fuorigrotta 1
Ganzhou 1
Gothenburg 1
Imola 1
Manado 1
Marconia 1
Massa 1
Mexico City 1
Newark 1
Ottawa 1
Prescot 1
Roppongi 1
Treviso 1
Vienna 1
Vientiane 1
Zirl 1
Totale 460
Nome #
Left ventricular outflow tract velocity-time integral improves outcome prediction in patients with secondary mitral regurgitation 88
Atrial amyloidosis: mechanisms and clinical manifestations 61
Role of Imaging in Cardiomyopathies 57
Clinical management of drug-induced cardiotoxicity in patients with HER-2+ breast cancer: current recommendations and future outlook 40
Echocardiographic findings in subjects with an amyloidogenic apolipoprotein A1 pathogenic variant 37
Echocardiography-Derived Forward Left Ventricular Output Improves Risk Prediction in Systolic Heart Failure 35
Sex-specific associations of myocardial perfusion imaging with outcomes in patients with suspected chronic coronary syndrome 32
Haemodynamic forces predicting remodelling and outcome in patients with heart failure treated with sacubitril/valsartan 32
Valvular heart disease in patients with cardiac amyloidosis 30
Wild-type transthyretin cardiac amyloidosis is not rare in elderly subjects: the CATCH screening study 27
Valve disease in cardiac amyloidosis: an echocardiographic score 27
Multi-chamber speckle tracking imaging and diagnostic value of left atrial strain in cardiac amyloidosis 24
Cardiovascular toxicity from therapies for light chain amyloidosis 22
Biomarkers in heart failure clinical trials. A review from the Biomarkers Working Group of the Heart Failure Association of the European Society of Cardiology 21
Approccio critico all’interpretazione dei trial cardiovascolari con risultati neutri o negativi 20
More cardiopulmonary effort testing needed in HFpEF! 18
Magnetic resonance imaging for diagnostic workup of embolic stroke of undetermined source: A systematic review 18
Critical Reading of cardiovascular trials with neutral or negative results 17
Partial Lipodystrophy and LMNA p.R545H Variant 17
Management and treatment of cardiotoxicity due to anticancer drugs: 10 questions and answers 16
Galectin-3 and Risk for Cancer or Heart Failure: Does Sex Matter? 15
Non-pegylated liposomal doxorubicin in older adjuvant early breast cancer patients: cardiac safety analysis and final results of the COLTONE study 15
Exercise oscillatory ventilation in heart failure and brain–lung–heart–muscle crosstalk 14
Treatment Options in AF Patients with Cancer; Focus on Catheter Ablation 14
Disease features and management of cardiomyopathies in women 14
The Mayo ATTR‐CM score versus other diagnostic scores and cardiac biomarkers in patients with suspected cardiac amyloidosis 12
Use of new and emerging cancer drugs: what the cardiologist needs to know 11
Prevalence and clinical outcomes of isolated or combined moderate to severe mitral and tricuspid regurgitation in patients with cardiac amyloidosis 11
Post-acute cardiac complications following SARS-CoV-2 infection in partial lipodystrophy due to LMNA gene p.R349W mutation 9
Assessing cardiac mechanics through left ventricular haemodynamic forces 9
Response to ‘Is the left atrium the key in the amyloid imaging lock?’ 6
Totale 769
Categoria #
all - tutte 9.275
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.275


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202347 0 0 0 0 4 5 4 6 18 5 5 0
2023/2024246 1 0 48 34 10 22 30 8 6 16 14 57
2024/2025476 40 48 85 51 121 122 9 0 0 0 0 0
Totale 769